Similar articles

• Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.

  Sanclemente G, Herrera S, Tyring SK, Rady PL, Zuleta JJ, Correa LA, He Q, Wolff JC. Sanclemente G, et al. J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1054-60. doi: 10.1111/j.1468-3083.2007.02169.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17714124 Clinical Trial.
• Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.

  Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C. Saiag P, et al. Br J Dermatol. 2009 Oct;161(4):904-9. doi: 10.1111/j.1365-2133.2009.09210.x. Epub 2009 May 15. Br J Dermatol. 2009. PMID: 19466962 Clinical Trial.
• Imiquimod: a cytokine inducer.

  Dahl MV. Dahl MV. J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S205-8. doi: 10.1067/mjd.2002.126586. J Am Acad Dermatol. 2002. PMID: 12271278 No abstract available.
• Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.

  Schöfer H, Tatti S, Lynde CW, Skerlev M, Hercogová J, Rotaru M, Ballesteros J, Calzavara-Pinton P. Schöfer H, et al. Int J STD AIDS. 2017 Dec;28(14):1433-1443. doi: 10.1177/0956462417711622. Epub 2017 May 31. Int J STD AIDS. 2017. PMID: 28566057 Review.
• [Mechanisms of imiquimod indirect antiviral activity].

  Hober D, Ajram L, Chehadeh W, Lazrek M, Goffard A, Dewilde A, Wattré P. Hober D, et al. Ann Biol Clin (Paris). 2005 Mar-Apr;63(2):155-63. Ann Biol Clin (Paris). 2005. PMID: 15771973 Review. French.